Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Clinical trial NCT01953003 · COMPLETED
Trial details
- NCT number
- NCT01953003
- Sponsor
- Pierre Fabre Medicament
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2017-07-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.